Joint modeling of both monogenic variant status and polygenic score estimated that the risk for breast cancer among carriers of a BRCA1 or BRCA2 variant ranges from 1.43-fold to 16.68-fold increased risk across percentiles of the polygenic score (Fig. 2b). This evidence concerns the gene BRCA2 and breast carcinoma.